News | Proton Therapy | January 25, 2018

IBA Announces First Patient Treated with Proteus Plus in The Netherlands

UMC Groningen Proton Therapy Center treated the first patient on its IBA Proteus Plus within 13 months of installation 

IBA Announces First Patient Treated with Proteus PLUS in The Netherlands

January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG) Proton Therapy Center treated the first patient on its IBA Proteus Plus in January 2018. UMCG successfully treated the first patient within 13 months of installation of the system. This is the first patient to receive proton beam therapy in The Netherlands.

The Proteus Plus at UMCG is configured with two gantry treatment rooms equipped with IBA’s pencil beam scanning (PBS) and cone beam computed tomography (CBCT) large field of view image guidance. These technologies improve the precision of treatment and enable adaptive treatment. The center also benefits from the most advanced room matching available, enabling maximum flexibility of room scheduling and allowing for a minimum 30 percent reduction in commissioning time, therefore, giving maximum flexibility for patient treatment. Rooms are also supplied with IBA’s wireless hand pendant, the only wireless patient remote control in the radiation therapy industry, according to the company, as well as a new-generation, highaccuracy and precision Patient Positioning System.

The UMCG Proton Therapy Center is the first of three centers planned to treat patients in The Netherlands, according to the company.

J.A. Hans Langendijk, Chair, Department of Radiation Oncology at UMCG Proton Therapy Center, added: “In 2009, a team of experts in The Netherlands evaluated the benefits of proton therapy and how to select the patients appropriately. They estimated that over 5800 patients annually could benefit from this cutting-edge cancer treatment in The Netherlands. Three centers are currently being built across the country and we are proud that the UMCG is now the first to deliver proton therapy treatment to patients.

For more information:


Related Content

Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and